Thyme Care
Nashville · Health Care
Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers, and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology
Funding history
- Series E · $125.0M · Sep 2026
- Series D · $97.0M · Sep 2025
- Venture - Series Unknown · $54.5M · Jul 2024
- Series C · $95.0M · Jul 2024
- Venture - Series Unknown · $49.0M · Aug 2023
Recent signals
- Sep 02, 2026: Raised $125.0M in Series E
- Jul 15, 2026: Thyme Care Appoints Brad Diephuis as Chief Executive Officer and Marcia Macphearson as Chief Operating Officer
- Dec 15, 2025: Thyme Care partners with CenterWell to enhance cancer care support across seven states.
- Sep 25, 2025: Raised $97.0M in Series D
- Jul 23, 2024: Raised $54.5M in Venture - Series Unknown
- Jul 16, 2024: Raised $95.0M in Series C
- May 02, 2024: Thyme Care Appoints Dr. Julia Frydman as First Medical Director for Palliative Care
- Aug 22, 2023: Raised $49.0M in Venture - Series Unknown
See plans & pricing → Track Thyme Care’s funding, hiring and signals, with verified contacts, on Fundz.
Fundz watches Thyme Care across 18 signal types, from funding and M&A to exec moves and hiring.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.